Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 2Phase 3 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Gynecologic 2Gastrointestinal 2Breast 2

Conditions

Uterine Cervical Neoplasms 2Breast Neoplasms 1

Interventions

Paclitaxel 233Carboplatin 217Bevacizumab 139Cisplatin 136pembrolizumab 89Gemcitabine 69olaparib 54Docetaxel 47Topotecan 44Radiotherapy 43liposomal doxorubicin 41Taxes 41niraparib 38Cyclophosphamide 36Doxorubicin 30Drug Therapy 29Letrozole 28Nivolumab 27Magnetic Resonance Spectroscopy 25Immunoglobulin G 25Disulfides 24Oxaliplatin 23Albumin-Bound Paclitaxel 23durvalumab 22apatinib 21Etoposide 21Brachytherapy 21lenvatinib 20camrelizumab 20Specimen Handling 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Restraint, Physical × Gynecologic × Clear all
NCT07276360 2026-03-27

HypoRTCx-UG

Uganda Cancer Institute

Phase 2 Recruiting
278 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT00632047 2013-08-26

Early Detection of Breast Cancer and Cervical Cancer in Women in India

National Cancer Institute (NCI)

Phase 2 Unknown
151,538 enrolled
BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡